RJ Owens

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease

G. Müller-Newen, F. Powrie, B. Linggi, 2017, Zeitschrift für Gastroenterologie.